Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression

Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic var...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2021-03, Vol.143 (13), p.1302-1316
Hauptverfasser: Gacita, Anthony M., Fullenkamp, Dominic E., Ohiri, Joyce, Pottinger, Tess, Puckelwartz, Megan J., Nobrega, Marcelo A., McNally, Elizabeth M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1316
container_issue 13
container_start_page 1302
container_title Circulation (New York, N.Y.)
container_volume 143
creator Gacita, Anthony M.
Fullenkamp, Dominic E.
Ohiri, Joyce
Pottinger, Tess
Puckelwartz, Megan J.
Nobrega, Marcelo A.
McNally, Elizabeth M.
description Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability. We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes, and . Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data. Multiple enhancers were identified and validated for and , including a key enhancer that regulates the switch from expression to expression. Deletion of this enhancer resulted in a dose-dependent increase in and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of Gene editing to remove the enhancer that harbors this variant markedly reduced expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy. Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.
doi_str_mv 10.1161/CIRCULATIONAHA.120.050432
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8009836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480403810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</originalsourceid><addsrcrecordid>eNpVkV9P2zAUxS20aXRsXwFlb3tJuf4Xxy-TqqhApQLTBLxaruMQb6nd2elYv_1ctUPwZF37nOOj-0PoC4YpxhW-aBY_mofl7H5xdzu7nk0xgSlwYJScoAnmhJWMU_kOTQBAloIScoo-pvQzjxUV_AM6pZSJmjA5QY9X1tvRmeJRR6dHF3zhfDH3vfbGxlTchNZ1zqai0bF1Yb0LGz32u2JvK-Z_N9GmtDdp3xbfY3g6zp_Q-04PyX4-nmfo4XJ-31yXy7urRTNbloZL4GXLZNdRQxjP9YVeEdYyU3W8Mi20hDHQkhvRVZKKupYcqFjJikOnV9gaQgQ9Q98OuZvtam1bY_0Y9aA20a113KmgnXr74l2vnsIfVefV1LTKAV-PATH83to0qrVLxg6D9jZskyKsBga0xpCl8iA1MaQUbffyDQa156LeclGZizpwyd7z1z1fnP9BZAE7CJ7DMObF_xq2zzaq3uph7FUmBxSwKAmQ3IQClPsrTv8BRHabtQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2480403810</pqid></control><display><type>article</type><title>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete - AutoHoldings</source><creator>Gacita, Anthony M. ; Fullenkamp, Dominic E. ; Ohiri, Joyce ; Pottinger, Tess ; Puckelwartz, Megan J. ; Nobrega, Marcelo A. ; McNally, Elizabeth M.</creator><creatorcontrib>Gacita, Anthony M. ; Fullenkamp, Dominic E. ; Ohiri, Joyce ; Pottinger, Tess ; Puckelwartz, Megan J. ; Nobrega, Marcelo A. ; McNally, Elizabeth M.</creatorcontrib><description>Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability. We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes, and . Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data. Multiple enhancers were identified and validated for and , including a key enhancer that regulates the switch from expression to expression. Deletion of this enhancer resulted in a dose-dependent increase in and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of Gene editing to remove the enhancer that harbors this variant markedly reduced expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy. Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.120.050432</identifier><identifier>PMID: 33478249</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Cardiac Myosins - metabolism ; Cardiomyopathies - genetics ; Disease Progression ; Gene Expression - genetics ; Genetic Variation - genetics ; Humans ; Myosin Heavy Chains - metabolism ; Promoter Regions, Genetic - genetics</subject><ispartof>Circulation (New York, N.Y.), 2021-03, Vol.143 (13), p.1302-1316</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</citedby><cites>FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</cites><orcidid>0000-0002-0455-2983 ; 0000-0002-2134-9661 ; 0000-0002-1221-719X ; 0000-0001-7627-7119</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,3676,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33478249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gacita, Anthony M.</creatorcontrib><creatorcontrib>Fullenkamp, Dominic E.</creatorcontrib><creatorcontrib>Ohiri, Joyce</creatorcontrib><creatorcontrib>Pottinger, Tess</creatorcontrib><creatorcontrib>Puckelwartz, Megan J.</creatorcontrib><creatorcontrib>Nobrega, Marcelo A.</creatorcontrib><creatorcontrib>McNally, Elizabeth M.</creatorcontrib><title>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability. We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes, and . Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data. Multiple enhancers were identified and validated for and , including a key enhancer that regulates the switch from expression to expression. Deletion of this enhancer resulted in a dose-dependent increase in and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of Gene editing to remove the enhancer that harbors this variant markedly reduced expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy. Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.</description><subject>Cardiac Myosins - metabolism</subject><subject>Cardiomyopathies - genetics</subject><subject>Disease Progression</subject><subject>Gene Expression - genetics</subject><subject>Genetic Variation - genetics</subject><subject>Humans</subject><subject>Myosin Heavy Chains - metabolism</subject><subject>Promoter Regions, Genetic - genetics</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV9P2zAUxS20aXRsXwFlb3tJuf4Xxy-TqqhApQLTBLxaruMQb6nd2elYv_1ctUPwZF37nOOj-0PoC4YpxhW-aBY_mofl7H5xdzu7nk0xgSlwYJScoAnmhJWMU_kOTQBAloIScoo-pvQzjxUV_AM6pZSJmjA5QY9X1tvRmeJRR6dHF3zhfDH3vfbGxlTchNZ1zqai0bF1Yb0LGz32u2JvK-Z_N9GmtDdp3xbfY3g6zp_Q-04PyX4-nmfo4XJ-31yXy7urRTNbloZL4GXLZNdRQxjP9YVeEdYyU3W8Mi20hDHQkhvRVZKKupYcqFjJikOnV9gaQgQ9Q98OuZvtam1bY_0Y9aA20a113KmgnXr74l2vnsIfVefV1LTKAV-PATH83to0qrVLxg6D9jZskyKsBga0xpCl8iA1MaQUbffyDQa156LeclGZizpwyd7z1z1fnP9BZAE7CJ7DMObF_xq2zzaq3uph7FUmBxSwKAmQ3IQClPsrTv8BRHabtQ</recordid><startdate>20210330</startdate><enddate>20210330</enddate><creator>Gacita, Anthony M.</creator><creator>Fullenkamp, Dominic E.</creator><creator>Ohiri, Joyce</creator><creator>Pottinger, Tess</creator><creator>Puckelwartz, Megan J.</creator><creator>Nobrega, Marcelo A.</creator><creator>McNally, Elizabeth M.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0455-2983</orcidid><orcidid>https://orcid.org/0000-0002-2134-9661</orcidid><orcidid>https://orcid.org/0000-0002-1221-719X</orcidid><orcidid>https://orcid.org/0000-0001-7627-7119</orcidid></search><sort><creationdate>20210330</creationdate><title>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</title><author>Gacita, Anthony M. ; Fullenkamp, Dominic E. ; Ohiri, Joyce ; Pottinger, Tess ; Puckelwartz, Megan J. ; Nobrega, Marcelo A. ; McNally, Elizabeth M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5905-d49ff3c2455047ab24d4c6f56cd0d2440a95c7f69378895037b9650fab1ec2273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiac Myosins - metabolism</topic><topic>Cardiomyopathies - genetics</topic><topic>Disease Progression</topic><topic>Gene Expression - genetics</topic><topic>Genetic Variation - genetics</topic><topic>Humans</topic><topic>Myosin Heavy Chains - metabolism</topic><topic>Promoter Regions, Genetic - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gacita, Anthony M.</creatorcontrib><creatorcontrib>Fullenkamp, Dominic E.</creatorcontrib><creatorcontrib>Ohiri, Joyce</creatorcontrib><creatorcontrib>Pottinger, Tess</creatorcontrib><creatorcontrib>Puckelwartz, Megan J.</creatorcontrib><creatorcontrib>Nobrega, Marcelo A.</creatorcontrib><creatorcontrib>McNally, Elizabeth M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gacita, Anthony M.</au><au>Fullenkamp, Dominic E.</au><au>Ohiri, Joyce</au><au>Pottinger, Tess</au><au>Puckelwartz, Megan J.</au><au>Nobrega, Marcelo A.</au><au>McNally, Elizabeth M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2021-03-30</date><risdate>2021</risdate><volume>143</volume><issue>13</issue><spage>1302</spage><epage>1316</epage><pages>1302-1316</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><abstract>Inherited cardiomyopathy associates with a range of phenotypes, mediated by genetic and nongenetic factors. Noninherited cardiomyopathy also displays varying progression and outcomes. Expression of cardiomyopathy genes is under the regulatory control of promoters and enhancers, and human genetic variation in promoters and enhancers may contribute to this variability. We superimposed epigenomic profiling from hearts and cardiomyocytes, including promoter-capture chromatin conformation information, to identify enhancers for 2 cardiomyopathy genes, and . Enhancer function was validated in human cardiomyocytes derived from induced pluripotent stem cells. We also conducted a genome-wide search to ascertain genomic variation in enhancers positioned to alter cardiac expression and correlated one of these variants to cardiomyopathy progression using biobank data. Multiple enhancers were identified and validated for and , including a key enhancer that regulates the switch from expression to expression. Deletion of this enhancer resulted in a dose-dependent increase in and faster contractile rate in engineered heart tissues. We searched for genomic variation in enhancer sequences across the genome, with a focus on nucleotide changes that create or interrupt transcription factor binding sites. The sequence variant, rs875908, disrupts a T-Box Transcription Factor 5 binding motif and maps to an enhancer region 2 kilobases from the transcriptional start site of Gene editing to remove the enhancer that harbors this variant markedly reduced expression in human cardiomyocytes. Using biobank-derived data, rs875908 associated with longitudinal echocardiographic features of cardiomyopathy. Enhancers regulate cardiomyopathy gene expression, and genomic variation within these enhancer regions associates with cardiomyopathic progression over time. This integrated approach identified noncoding modifiers of cardiomyopathy and is applicable to other cardiac genes.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>33478249</pmid><doi>10.1161/CIRCULATIONAHA.120.050432</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-0455-2983</orcidid><orcidid>https://orcid.org/0000-0002-2134-9661</orcidid><orcidid>https://orcid.org/0000-0002-1221-719X</orcidid><orcidid>https://orcid.org/0000-0001-7627-7119</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2021-03, Vol.143 (13), p.1302-1316
issn 0009-7322
1524-4539
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8009836
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete - AutoHoldings
subjects Cardiac Myosins - metabolism
Cardiomyopathies - genetics
Disease Progression
Gene Expression - genetics
Genetic Variation - genetics
Humans
Myosin Heavy Chains - metabolism
Promoter Regions, Genetic - genetics
title Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T15%3A31%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20Variation%20in%20Enhancers%20Modifies%20Cardiomyopathy%20Gene%20Expression%20and%20Progression&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Gacita,%20Anthony%20M.&rft.date=2021-03-30&rft.volume=143&rft.issue=13&rft.spage=1302&rft.epage=1316&rft.pages=1302-1316&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.120.050432&rft_dat=%3Cproquest_pubme%3E2480403810%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2480403810&rft_id=info:pmid/33478249&rfr_iscdi=true